Non Hodgkin's Lymphoma News and Research

RSS
The Non-Hodgkin lymphomas (NHLs) are a diverse group of hematologic cancers which encompass any lymphoma other than Hodgkin's Lymphoma.
Second potential immune checkpoint target for cancer immunotherapy announced by Compugen

Second potential immune checkpoint target for cancer immunotherapy announced by Compugen

Experimental medication increases muscle strength in cancer patients with low testosterone levels

Experimental medication increases muscle strength in cancer patients with low testosterone levels

GMCSF linked with rapid cognitive recovery in patients with cancer

GMCSF linked with rapid cognitive recovery in patients with cancer

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

Study: Quirky fruit fly gene can help develop new weapons against cancer

Study: Quirky fruit fly gene can help develop new weapons against cancer

Diabetes linked to increased blood cancer risk

Diabetes linked to increased blood cancer risk

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

Patients with type 2 diabetes have 20% increased risk of blood cancers

Patients with type 2 diabetes have 20% increased risk of blood cancers

Survivors of childhood cancers are at increased risk for GI cancers

Survivors of childhood cancers are at increased risk for GI cancers

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting

Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Study examines how SMIP-016 drug kills CLL cells

Study examines how SMIP-016 drug kills CLL cells

CTI announces results from PIX301 phase 3 trial of Pixuvri for NHL

CTI announces results from PIX301 phase 3 trial of Pixuvri for NHL

Enrollment complete in Xencor, MorphoSys’ MOR208 phase 1 trial for CLL

Enrollment complete in Xencor, MorphoSys’ MOR208 phase 1 trial for CLL

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

Treatment with IL-12 triggers T cell exhaustion in cancer patients

Treatment with IL-12 triggers T cell exhaustion in cancer patients